Ivermectin 3 mg: Clinical Trials

4 trials of Ivermectin 3 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1
Phase 21Unknown 1

Follow Ivermectin 3 mg: new trials by email Literature Review of Ivermectin 3 mg trials Research Report on Ivermectin 3 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda
Albendazole 400mg, Ivermectin 3 mg - Ascariasis
Phase 3Not yet recruitingJennifer Keiser4502026-10-012026-10-14
Co-administration of IVM and ALB in School-based Deworming in Uganda
Albendazole 400mg, Ivermectin 3 MG - Helminthiasis, Intestinal Worms
CompletedJennifer Keiser87672024-07-012024-12-20
Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis
Moxidectin 2 mg, Ivermectin 3 mg, Placebo - Strongyloides Stercoralis Infection
Phase 3CompletedJennifer Keiser3322022-02-052024-01-25
Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
Ivermectin 3 MG, Placebo - Covid19
Phase 2UnknownKitasato University2142020-09-162022-01-20

Conditions studied

Ascariasis (1)  ·  COVID-19 (1)  ·  Helminthiasis (1)

Sponsors

Jennifer Keiser (3)  ·  Kitasato University (1)

Countries

Uganda (2)  ·  Cambodia (1)  ·  Japan (1)

Top investigators

Jennifer Keiser, Prof. (2)  ·  Jennifer Keiser, Prof. Dr (1)  ·  Kunihiro K.Y Yamaoka, Ph.D (1)

Results publications

PMID 37283627, PMID 37949090